AmbioPharm, established in 2005 and based in North Augusta, South Carolina, USA, is a global peptide CDMO (Contract Development and Manufacturing Organization) that specializes in creating highly effective manufacturing procedures for peptide-based APIs at varying scales. The company runs two cGMP-compliant manufacturing sites, one in South Carolina, USA, and another in Shanghai, China. These facilities produce new chemical entities (NCEs) and generic peptide APIs for international clients. Both locations have undergone multiple FDA inspections with favorable results. AmbioPharm is capable of managing all forms of peptide manufacturing, from research to cGMP.
Products & Services
Bivalirudin
Bivalirudin non-sterile bulk drug substance
Cetrorelix Acetate
Contract Manufacturing for Peptides
Sites
Country
United States of AmericaCity
Beech Island
Country
People's Republic of ChinaCity
Shanghai
Shanghai AmbioPharm
Country
People's Republic of ChinaAddress
Chu Gong Lu
AmbioPharm
Country
United States of AmericaCity
Beech Island
Address
Dittman Court 1024, 29842 9404